PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Leukemia D007938 74 associated lipids
Leukemia P388 D007941 43 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukemia, Megakaryoblastic, Acute D007947 7 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Lung Diseases D008171 37 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Dong YG et al. Effects of 15-deoxy-delta12,14-prostaglandin J2 on cell proliferation and apoptosis in ECV304 endothelial cells. 2004 Acta Pharmacol. Sin. pmid:14704122
PPAR activators and gastroenterology. 2004 Drug News Perspect. pmid:15801147
Kumar AP et al. Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism. 2004 J. Biol. Chem. pmid:14668325
Böhm E et al. 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. 2004 J. Biol. Chem. pmid:14668348
Itoh K et al. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). 2004 Mol. Cell. Biol. pmid:14673141
Kasim-Karakas SE et al. Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. 2004 J. Clin. Endocrinol. Metab. pmid:14764771
Hirai H [Prostaglandin D2 in allergy: PGD2 has dual receptor systems]. 2004 Nippon Yakurigaku Zasshi pmid:14695454
Uehara Y [PGD(2)/L-PGDS system in hypertension and renal injury]. 2004 Nippon Yakurigaku Zasshi pmid:14695455
Miwa Y et al. Physiology and pharmacology of the prostaglandin J2 family. 2004 Nippon Yakurigaku Zasshi pmid:14695456
Arai I et al. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. 2004 Eur. J. Pharmacol. pmid:15556157
Chen Q et al. A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. 2004 Anal. Biochem. pmid:15556564
Kim BE et al. Involvement of Sox-4 in the cytochrome c-dependent AIF-independent apoptotic pathway in HeLa cells induced by Delta12-prostaglandin J2. 2004 Exp. Mol. Med. pmid:15557816
Józkowicz A et al. 15-deoxy-delta12,14-prostaglandin-J2 inhibits expression of eNOS in human endothelial cells. 2004 Prostaglandins Other Lipid Mediat. pmid:15560113
Abraha D et al. (S,S)-formoterol increases the production of IL-4 in mast cells and the airways of a murine asthma model. 2004 Int. Arch. Allergy Immunol. pmid:15031612
Rodway HA et al. Lysophosphatidic acid attenuates the cytotoxic effects and degree of peroxisome proliferator-activated receptor gamma activation induced by 15-deoxyDelta12,14-prostaglandin J2 in neuroblastoma cells. 2004 Biochem. J. pmid:15171682
Tanaka K et al. Effects of prostaglandin D2 on helper T cell functions. 2004 Biochem. Biophys. Res. Commun. pmid:15044085
Onozaki A et al. Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione. 2004 Biochem. Biophys. Res. Commun. pmid:15047143
Koda N et al. Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS. 2004 Arch. Biochem. Biophys. pmid:15047184
Saydam O et al. Transactivator protein BICP0 of bovine herpesvirus 1 (BHV-1) is blocked by prostaglandin D2 (PGD2), which points to a mechanism for PGD2-mediated inhibition of BHV-1 replication. 2004 J. Virol. pmid:15047795
Woolhiser MR et al. Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a. 2004 Clin. Immunol. pmid:15003814
Relic B et al. 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. 2004 J. Biol. Chem. pmid:15004016
Angeli V et al. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. 2004 J. Immunol. pmid:15004188
Lupi R et al. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:14625208
Tsuji T et al. Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells. 2004 Biol. Pharm. Bull. pmid:15467193
Konopleva M et al. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. 2004 Mol. Cancer Ther. pmid:15486192
Ishii T and Uchida K Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2. 2004 Chem. Res. Toxicol. pmid:15487891
Li Z et al. Neurotoxic prostaglandin J2 enhances cyclooxygenase-2 expression in neuronal cells through the p38MAPK pathway: a death wish? 2004 J. Neurosci. Res. pmid:15523637
Liu JD et al. Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression. 2004 Life Sci. pmid:14998722
Sabichi AL et al. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells. 2004 Cancer Epidemiol. Biomarkers Prev. pmid:15533896
Subbarayan V et al. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. 2004 Cancer Epidemiol. Biomarkers Prev. pmid:15533897
Eucker J et al. Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma. 2004 Anticancer Drugs pmid:15514564
Yoshida M et al. Methotrexate enhances prostaglandin D2-stimulated heat shock protein 27 induction in osteoblasts. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15519494
Giri S et al. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. 2004 J. Immunol. pmid:15470065
Mix KS et al. Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling. 2004 Mol. Pharmacol. pmid:14742672
Levonen AL et al. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. 2004 Biochem. J. pmid:14616092
Reddy RC et al. Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands. 2004 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:14617516
Ehara N et al. Activators of PPARgamma antagonize protection of cardiac myocytes by endothelin-1. 2004 Biochem. Biophys. Res. Commun. pmid:15358182
Yuan ZY et al. PPAR-gamma ligands inhibit the expression of inflammatory cytokines and attenuate autoimmune myocarditis. 2004 Chin. Med. J. pmid:15361304
Dugo L et al. 15d-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria. 2004 Eur. J. Pharmacol. pmid:15364008
Li L et al. Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. 2004 J. Hepatol. pmid:15336443
Hirata Y et al. Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells. 2004 Brain Res. pmid:15342272
Grau R et al. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. 2004 Cancer Res. pmid:15289320
Yoshimura-Uchiyama C et al. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. 2004 Clin. Exp. Allergy pmid:15298571
Kielian T et al. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). 2004 J. Neurochem. pmid:15312171
Weber SM et al. PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:15315910
Szczeklik W et al. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. 2004 J. Allergy Clin. Immunol. pmid:15316498
Tanaka Y et al. Enhanced release of prostaglandin D2 during re-incubation of RAW 264.7 macrophage-like cells after treatment of both lipopolysaccharide and non-steroidal anti-inflammatory drugs. 2004 Biol. Pharm. Bull. pmid:15256727
Jawerbaum A et al. Influence of peroxisome proliferator-activated receptor gamma activation by its endogenous ligand 15-deoxy Delta12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. 2004 Mol. Hum. Reprod. pmid:15258247
Zhao ML et al. 15-deoxy-delta (12,14)-PGJ2 inhibits astrocyte IL-1 signaling: inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression. 2004 J. Neuroimmunol. pmid:15265671
Zhang X et al. Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells. 2004 Blood pmid:15265789
Azuma Y et al. Induction of proliferation by 15-deoxy-delta12,14-prostaglandin J2 and the precursors in monocytic leukemia U937. 2004 Pharmacology pmid:15240994
Zhang C et al. The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells. 2004 J. Invest. Dermatol. pmid:15245439
Siavash H et al. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells. 2004 Cancer Lett. pmid:15194221
Li Z et al. Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. 2004 Biochem. Biophys. Res. Commun. pmid:15194490
Ruiz PA et al. 15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity. 2004 J. Biol. Chem. pmid:15199053
Shimomura K et al. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion. 2004 J. Pharmacol. Exp. Ther. pmid:15201343
Hawcroft G et al. Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. 2004 Cancer Lett. pmid:15172124
Son DJ et al. Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15172681
Brummond KM et al. The first total synthesis of 15-deoxy-Delta12,14-prostaglandin J2 and the unambiguous assignment of the C14 stereochemistry. 2004 Org. Lett. pmid:14723515
Moore RM et al. Physiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells. 2003 Feb-Mar Placenta pmid:12566244
Kanaoka Y and Urade Y Hematopoietic prostaglandin D synthase. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895599
Nagata K and Hirai H The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895600
Powell WS A novel PGD(2) receptor expressed in eosinophils. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895601
Kabashima K and Narumiya S The DP receptor, allergic inflammation and asthma. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895602
Bishop-Bailey D and Warner TD PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist. 2003 FASEB J. pmid:12897060
Souza SC et al. TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. 2003 J. Cell. Biochem. pmid:12898507
Zhuang H et al. Prostaglandins of J series control heme oxygenase expression: potential significance in modulating neuroinflammation. 2003 Ann. N. Y. Acad. Sci. pmid:12853315
Pestel S et al. Inhibition of prostaglandin D2 clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelate. 2003 Biochem. Pharmacol. pmid:12906929
Pritts EA et al. Peroxisome proliferator-activated receptor-gamma ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element. 2003 Fertil. Steril. pmid:12909507
Zanoni G et al. A --> J prostaglandin swap: a new tactic for cyclopentenone prostaglandin synthesis. 2003 J. Org. Chem. pmid:12919053
Nencioni A et al. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling. 2003 J. Immunol. pmid:14607914
Zhang M et al. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism]. 2003 Zhonghua Yi Xue Za Zhi pmid:12921638
Kim BE et al. Cytochrome C-dependent Fas-independent apoptotic pathway in HeLa cells induced by delta12-prostaglandin J2. 2003 Exp. Mol. Med. pmid:14508070
Urade Y and Eguchi N [Sleep substances]. 2003 No To Shinkei pmid:12649899
Smith SA et al. Effects of peroxisome proliferator-activated receptor gamma ligands ciglitazone and 15-deoxy-delta 12,14-prostaglandin J2 on rat cultured cerebellar granule neuronal viability. 2003 J. Neurosci. Res. pmid:12774315
Armoni M et al. Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect. 2003 J. Biol. Chem. pmid:12777391
Liu H et al. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. 2003 Breast Cancer Res. Treat. pmid:12779083
Villegas I et al. A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice. 2003 Int. Immunopharmacol. pmid:14636824
Mitsumori S et al. Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 1. Bicyclo[2.2.1]heptane derivatives. 2003 J. Med. Chem. pmid:12773047
Inoue K et al. Effect of 15-deoxy-delta 12,14-prostaglandin J2 on acute lung injury induced by lipopolysaccharide in mice. 2003 Eur. J. Pharmacol. pmid:14642794
Mitsumori S et al. Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 2. 6,6-Dimethylbicyclo[3.1.1]heptane derivatives. 2003 J. Med. Chem. pmid:12773048
Ide T et al. Activation of nuclear receptors by prostaglandins. 2003 Thromb. Res. pmid:14592554
Kim EJ et al. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. 2003 J. Pharmacol. Exp. Ther. pmid:12966153
Yagami T et al. Novel binding sites of 15-deoxy-Delta12,14-prostaglandin J2 in plasma membranes from primary rat cortical neurons. 2003 Exp. Cell Res. pmid:14597421
Collin M and Thiemermann C The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock. 2003 Eur. J. Pharmacol. pmid:12969773
Caivano M et al. 15-Deoxy-Delta12,14-prostaglandin J2 regulates endogenous Cot MAPK kinase kinase 1 activity induced by lipopolysaccharide. 2003 J. Biol. Chem. pmid:14557273
Murakami Y et al. Inhibition of monosodium urate monohydrate crystal-induced acute inflammation by retrovirally transfected prostaglandin D synthase. 2003 Arthritis Rheum. pmid:14558100
Niyonsaba F et al. Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells. 2003 Curr Drug Targets Inflamm Allergy pmid:14561157
Hata AN et al. Expression and molecular pharmacology of the mouse CRTH2 receptor. 2003 J. Pharmacol. Exp. Ther. pmid:12721327
Yee LD et al. The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells. 2003 Breast Cancer Res. Treat. pmid:12725418
Oliva JL et al. The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12684535
Paumi CM et al. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. 2003 Biochemistry pmid:12731885
Gosset P et al. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. 2003 J. Immunol. pmid:12734337
Lu S et al. Specific gene expression of isoforms in cyclooxygenase pathway to generate PGJ2 derivatives during the differentiation of 3T3-L1 adipocytes. 2003 Adv. Exp. Med. Biol. pmid:12751756
Imaizumi T et al. 15-deoxy-delta(12,14)-prostaglandin J2 inhibits IFN-gamma-induced galectin-9 expression in cultured human umbilical vein endothelial cells. 2003 Int. Arch. Allergy Immunol. pmid:12759491
Kajekar R et al. Role of cyclooxygenase activation and prostaglandins in antigen-induced excitability changes of bronchial parasympathetic ganglia neurons. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12618420
Wanichkul T et al. Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells. 2003 Fertil. Steril. pmid:12620489
Monneret G et al. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils. 2003 J. Pharmacol. Exp. Ther. pmid:12490611
Li L et al. RasGRP4 regulates the expression of prostaglandin D2 in human and rat mast cell lines. 2003 J. Biol. Chem. pmid:12493770
Winnett G et al. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy. 2003 Int. J. Cancer pmid:12494466